. Although the dose and duration of therapy with cyclophosphamide (cy) are known to influence the incidence of subsequent relapses in children with nephrotic syndrome, other factors which predispose to relapses after cy have not been extensively evaluated. The clinical course of 30 children with steroidsensitive, frequently-relapsing nephrotic syndrome was analyzed. Each of the pts had a renal biopsy at the time of initiation of cy, and all of the children had a complete remission while on cy (2 mg/Kg/d for 12 wks). After cy, one or more relapses occurred in 14 pts, while 16 pts had a sustained remission. There were no significant differences between the two groups of pts concerning: 1) age at onset (4.5 vs 4.9 yrs), 2) intervalbetween onset and cy (6.35 vs 6.52 yrs) , and 3) duration of follow-up after cy (4.0 vs 4.4 yrs).
f o r 9 t o 49 days and 8 recelved s u p p o r t i v e therapy o n l y .There were no s l g n l f l c a n t d l f f e r e n c e s between t h e 2 groups in age,sex, prevalence o f e x t r a r e n a l m a n l f e s t a t i o n s , l o w e s t hematocrlt and p l a t e l e t count ,number o f transfusions needed,durat Ion o f thrombo cytopenla o r number o f p t s r e q u l r l n g d l a l y s l s . T h e t r e a t e d p t s were o l l g u r l c and requlred d i a l y s l s f o r a s h o r t e r period o f time than t h e u n t r e a t e d p t s ( d a y s w i t h u r i n a r y output<200ml/d/day:1.6 f0.89,range 1-3 compared t o 5.63f5.83,range O-19;days between ad mlsslon and l a s t d l a l y s l s 2.15f2.47,range 0-6 compared t o 4 . 8 t 8.76.range 0-26) .The d t f f e r e n c e s however were n o t sign1 f l c a n t . A f t e r p e r l o d s o f follac-up ranging from 3.5 t o 18.25 months,all p t s had g r a m normally and had GFR's ranglng from 90 t o 196ml/ nln/l.73mz.
None had hematuria.0ne o f t h e u n t r e a t e d p t s had mlld p r o t e l n u r l a (7mg/rna/hr on o v e r n l g h t specimen).
We conclude t h a t ASA and 0 do not a l t e r t h e long t e n prognos l s o f HUS.The s h o r t e r d u r a t l o n o f o l l g u r l a and o f dependence on d l a l y s l s In o u r t r e a t e d pts,though n o t s t a t l s t l c a l l y s l g n l f l c a n t auggests s l a r g e r s t u d y Is warranted. a l , Torrance, CA. 1 Plasma r e n i n a c t i v i t y (PRA) and a l d o s t e r o n e (Aldo) l e v e l s a r e I
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-. high i n t h e newborn. The purpose o f t h i s s t u d y was t o determine t h e e f f e c t s o f l a b o r and d e l i v e r y on PRA and Aldo i n t h e newborn; and t o determine how PRA and Aldo l e v e l s change d u r i n g t h e e a r l y newborn period. 28 f u l l t e r m and 6 preterm i n f a n t s , 32-36 weeks g e s t a t i o n , were s t u d i e d a t 4, 2 , 4, 24 and 4 8 hrs. All were borr a f t e r an uncomplicated vaginal d e l i v e r y (VAG-D) w i t h apgar s c o r e s >7 a t 5 min. PRA and Aldo were measured by RIA. The Mean and SEP (ng/ml/hr) PRA i n umbilical vein (UV) plasma was 16.2 ? 5.1 a f t e r C-Sec a l o n e , N=6; 44.1 + 8.9 a f t e r C-Sec i n l a b o r . N=16 pq.05; and 34.7 f 4 . 3 a f t e r VAG-0, N.28, pc.05. The l a t t e r two groups d i d n o t d i f f e r . There were no d i f f e r e n c e s i n UV vs V A PRA o r Aldo l e v e l s . The UV PRA l e v e l i n reclampsia (52.6 f 5.0) was h i g h e r t h a n i n normal VAG-D (p<.057. S e r i a l PRA values i n f u l l term i n f a n t s decreased from 34.7 ? 4.3 i n UV plasma t o 1 8 . 3 f 4.4 a t 2 h r s (p<0.05), and were s t a t i s t i c a l l y s i m i l a r (30.7 1 4.4) a t 24 hours. Aldo l e v e l s a l s o r e m i n e d unchan ed. UV PRA and Aldo l e v e l s a f t e r VAG-D and during t h e subsequen! 4 8 h r s o f l l f e were s i m i l a r i n t h e preterm and f u l l t e r m i n f a n t s . Conclusions: a ) Labor i n c r e a s e s PRA l e v e l s i n f u l l t e r m and preterm i n f a n t s . b ) Preclampsia i s a s s o c i a t e d with high.PRA cord blood l e v e l s . 5 ) PRA and Aldo l e v e l s do n o t f a l l during t h e e a r l y newborn period. s u g g e s t i n g c o n t i n u a l s t i m u l a t i o n a f t e r d e l i v e r y . I C e f a z o l i n h a s n o t been s t u d i e d b e f o r e i n c h i l d r e n w i t h renal i n s u f f i c i e n c y . A s i n g l e d o s e of 7 mq/kg was a d m i n i s t e r e d to 1 0 c h i l d r e n (14-16 y r ) w i t h v a r y i n g degrees o f r e n a l impairment (Crp I), and to 10 c h i l d r e n 17-11 yr) undergoing h e m d i a l y s i s (Crp II). Serum h a l f -l i f e (T/2) i n hours was c a l c u l a t e d from disappearance c u r v e s a n d c r e a t i n i n e c l e a r a n c e was o b t a i n e d (ml/ m i d 1 . 7 3 n?). I n C r p I o n e c h i l d had a CICr of 5 7 ml/min end a T/2 of 4.8 h r . Three c h i l d r e n w i t h CICr o f 15-25 ml/min had a T/2 of 19-23 hr. m u r c h i l d r e n had a CICr o f 8-10 ml/min and had a T/2 o f 29-40 hr. Two c h i l d r e n w i t h CICr l e s s t h a n 5 ml/min had T/2 v a l u e s g r e a t e r t h a n 58 hr. Normal a d u l t s have T/2 of 1.8-1.9 h r . S t u d i e s have shown a d u l t s w i t h CICr o f 40-60 ml/min t o have T/2 of a b o u t 5 h r s . A d u l t s w i t h lower CICr had l e s s p r o l o n g a t i o n of T/2 t h a n d i d the c h i l d r e n . The d r u q d i d n o t a l t e r t h e t u b u l a r r e a b s o r p t i o n of phosphate o r t h e c l e a r a n c e of u r i c a c i d . I n G r p 1 1 t h e T/2 was 8.25-29.5 hrs. A v a l u e o f 6.5 hrs. has been rep o r t e d for a d u l t s . The T/2 i n c r e a s e d a s t h e e f f i c i e n c y of d i al y s i s , e s t i m a t e d by p e r c e n t r e d u c t i o n of BUN and c r e a t i n i n e , fell. T/2 of c e f a m l i n is prolonged i n c h i l d r e n w i t h r e n a l i ns u f f i c i e n c y a n d t h e degree o f p r o l o n g a t i o n is comparable t o a d u l t s when the CICr is o n l y m d e r a t e l y reduced. A s t h e CICr f a l l s f u r t h e r , t h e T/2 i n c r e a s e s mre a m n g t h e c h i l d r e n .
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T/2
for c h i l d r e n on h e m d i a l y s i s v a r i e s w i t h the e f f i c i e n c y of d i al y s i s . Supported i n p a r t by N I H g r a n t s RR-75 and RR-5624. The antihypertensive agent clonidine (C) appears to lower blood pressure (BP) via central alpha-adrenergic stimulation. In order to determine safety and efficacy of this drug, an openlabel study was done in 16 hypertensive children and adolescents (ages 7-18). C (.15 to l.lrng/day) was used when other agents ha failed or were medically undesirable; informed consent was obtained. 8 patients (P) had post-transplant hypertension; 6 , chronic nephritides, 1, polycystic-hamartomatous kidneys; and 1, essential hypertension. 10 of 16 P had BP controlled on C plus diuretic; in another 5, all with severe hypertension, C clearly improved BP control, but other agents were still required. No control was obtained in only one P (allograft renal artery disease in whom surgical repair failed). No P had hematologic or chemical abnormalities induced by the druq. Except for somnolence in 8 P, no problems occurred while regularly taking C. However, 1 of the 10 P on C plus diuretic had 2 episodes of hypertension with encephalopathy within 16 hours of drug discontinuation due to vomiting. In 2 additional patients rebound hypertension was suspected but not proven. 2 P on C plus addition a1 agents had episodes of symptomatic hypotension when C was added to their regimen. Thus C appears to be a useful and generally safe agent in children; however, rebound hypertension es it important to determine patient compliance and awareness the effect of vomitins e~isodes before the drus is orescribed In 14 immature (30-45 day) Elunich-Wistar rats with surface glomeruli accessible tomicropuncture, glomerular capillary (PGc) and Bowman's space (PT) hydraulic pressures, efferent arteriolar oncotic pressure (nE), single nephron (SN)GFR, initial glomerular plasma flow rate (QA), afferent (RA) and efferent (RE) arteriolar resistances, and glomerular capillary ultrafiltration coefficient (Kf) were determined under euvolemic conditions. Results are compared with those from 14 adult (70-100 day) rats studied under similar conditions. (Mean f SE, t P <.01) Thus, mean values for PGC, PT and SNFF in immature were essen tially the same as those in adult. Since the net force for ultrafiltration at the efferent end of the glomerular capillary network (given by PGC-P~-IIE) was essentially zero in immature an adult alike, Kf was not a factor limiting SNGFR in either group. Instead, the lower values for SNGFR per gram kidney weight (KW) in immature than adult are primarily a consequence of lower QA/ gKW, the latter due, at least in part, to markedly higher RA and RE. The causes for these higher resistances, whether structural or humoral, remains to be determined.
